Loading...
NPI 1720421118 · Honolulu, HI · Anatomic Pathology & Clinical Pathology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Casey Phan is a anatomic pathology & clinical pathology physician provider located in Honolulu, Hawaii. This profile covers 18 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Casey Phan |
| Address | 1301 Punchbowl Street |
| City | Honolulu |
| State | HI |
| ZIP | 96813 |
| Taxonomy | Anatomic Pathology & Clinical Pathology Physician |
| NPI Enumerated | April 16, 2013 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $296.5K |
| Medicaid | $830 |
This NPI is an anatomic pathology & clinical pathology physician whose Medicare billing is concentrated in surgical pathology and ancillary pathology services. The top Medicare lines by revenue are 88305 ($136.3K), G0416 ($41K), and 88341 ($37.8K), which — based on their descriptions — indicate routine gross and microscopic surgical pathology, prostate needle‑biopsy pathology, and immunohistochemical/single‑antibody interpretation activity. These codes together drive the core clinical workflows reflected in the Medicare revenue mix.
Revenue concentration is high on Medicare: the precomputed top 3 Medicare codes account for 72.4% of this provider's total Medicare revenue while total Medicare revenue is $296.5K. On Medicaid the revenue footprint is effectively entirely concentrated in a single code: the precomputed top‑3 Medicaid codes account for 100.0% of Medicaid revenue and Medicaid revenue totals $829, all from 88305. This indicates a narrow code-level revenue base, especially on Medicaid.
Payer mix is heavily Medicare‑skewed: Medicare revenue ($296.5K) dwarfs Medicaid revenue ($829), so the provider is effectively a Medicare provider with minimal Medicaid activity. The small absolute Medicaid total and its concentration in a single surgical‑pathology code suggest little participation in the state Medicaid market or minimal billed Medicaid volume.
National competitive standing on the provider's top Medicare codes shows relatively high percentile ranks but are described in the file as routine activity. 88305 ranks #1136 of 14580 (92th percentile; typical, unremarkable volume for this code), G0416 ranks #155 of 2465 (94th percentile; typical, unremarkable volume for this code), and 88341 ranks #959 of 10274 (91th percentile; typical, unremarkable volume for this code). In plain terms, the provider posts solid activity on these national leaderboards but the dataset characterizes those volumes as typical rather than indicative of a uniquely dominant national position.
Statewide competitive standing on Medicaid is minimal: 88305 on Medicaid ranks #24 of 25 in-state (4th percentile; typical, unremarkable volume for this code), reflecting very low Medicaid billing compared with in‑state peers. Even though 88305 is the sole Medicaid revenue source, its in‑state rank implies the provider is a modest Medicaid participant in Hawaii.
Tenure and stability: the NPI was enumerated on 2013-04-16 (~13 years ago), indicating more than a decade of billing history under this NPI. This length of enrollment supports interpretation of the observed patterns as established billing behavior rather than a transient reporting artifact.
Code‑level service mix points to a pathology practice that augments core surgical pathology with immunohistochemistry and cytopathology services. Beyond 88305, notable Medicare contributions come from immunostain and ancillary pathology codes such as 88341 ($37.8K, 12.7% of Medicare revenue), 88342 ($18.9K, 6.4%), and 88344 ($8.8K, 2.9%), suggesting routine use of IHC/additional stains in the practice workflow.
There are no codes in the top lists labeled as extreme outliers; most listed codes are characterized as "typical, unremarkable volume for this code" even where percentiles are high or low. This pattern implies the provider's volumes are within the expected distribution for pathologists doing surgical pathology and related ancillary testing rather than showing anomalous utilization on specific CPT/HCPCS codes.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
18 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 2,900 | $50 | $136.3K |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 150 | $280 | $41K |
| 88341 | The lab analyst applies an additional single antibody stain on a slide or slides prepared from the same patient specimen as the initial antibody stain, such as tumor tissue. Then a qualified… | 660 | $60 | $37.8K |
| 88342 | The lab analyst applies an initial single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 280 | $70 | $18.9K |
| 88312 | The lab analyst performs the technical lab steps to stain a specimen with a special stain. This code applies to Group I for microorganisms. A qualified provider, typically a pathologist, interprets… | 170 | $80 | $13.5K |
| 88307 | The physician, typically a pathologist, performs a level V examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 110 | $100 | $11.4K |
| 88173 | The lab analyst performs the technical lab test to analyze a cytopathology specimen from a fine needle aspirate and then interprets and reports the results. | 100 | $100 | $10.7K |
| 88344 | The lab analyst applies a single multiplex antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 70 | $130 | $8.8K |
| 88360 | The lab analyst applies a single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist, evaluates the… | 50 | $90 | $4.2K |
| 88304 | The physician, typically a pathologist, performs a level III examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 110 | $40 | $3.9K |
Showing 1–10 of 18
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 18 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 20 | $50 | $830 |
How this provider's Medicaid billing volume and revenue compare to other Hawaii providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Hawaii median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 24 | 30 | 1,750 | $70 | $378K |
Other providers in the same ZIP code as Casey Phan, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.